William Bonello
Stock Analyst at Craig-Hallum
(4.93)
# 171
Out of 4,581 analysts
287
Total ratings
66.7%
Success rate
33.3%
Average return
Main Sectors:
Stocks Rated by William Bonello
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PSNL Personalis | Maintained: Buy | n/a | $11.98 | - | 15 | Jul 17, 2026 | |
| CDNA CareDx | Maintained: Hold | $35 | $36.36 | -3.74% | 33 | Jul 16, 2026 | |
| JBHT J.B. Hunt Transport Services | Maintained: Buy | n/a | $280.96 | - | 1 | Jul 9, 2026 | |
| NEO NeoGenomics | Maintained: Buy | n/a | $13.14 | - | 20 | Jul 9, 2026 | |
| NTRA Natera | Maintained: Buy | n/a | $258.03 | - | 20 | Jul 9, 2026 | |
| SRTA Strata Critical Medical | Maintained: Buy | n/a | $5.14 | - | 4 | Jun 26, 2026 | |
| WGS GeneDx Holdings | Maintained: Buy | n/a | $60.54 | - | 31 | Jun 9, 2026 | |
| SOPH SOPHiA GENETICS | Maintained: Buy | n/a | $5.65 | - | 16 | Jun 8, 2026 | |
| SERA Sera Prognostics | Initiated Coverage: Buy | $6 | $2.05 | +192.68% | 1 | Jun 4, 2026 | |
| VCYT Veracyte | Maintained: Buy | n/a | $55.61 | - | 12 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.418 | +617.70% | 11 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $5.45 | +83.49% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.83 | - | 17 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $22.54 | - | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $22.22 | - | 13 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.07 | - | 15 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $4.40 | +127.27% | 6 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 | $145.47 | -14.07% | 21 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.31 | - | 1 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.75 | - | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.35 | +270.37% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $244.45 | n/a | 2 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $37.46 | n/a | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $19.09 | n/a | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $19.71 | n/a | 1 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.74 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.41 | n/a | 1 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $131.06 | n/a | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.11 | n/a | 1 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $282.52 | n/a | 1 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $77.64 | n/a | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $16.44 | n/a | 1 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $16.53 | n/a | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $11.94 | n/a | 1 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.03 | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.06 | n/a | 1 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $6.06 | n/a | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $35.14 | n/a | 1 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.06 | n/a | 2 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $14.89 | n/a | 1 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $113.88 | n/a | 1 | Feb 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $61.51 | n/a | 1 | Nov 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.15 | n/a | 2 | Oct 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $21.81 | n/a | 1 | Apr 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $21.97 | n/a | 1 | Jan 29, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $74 | $231.84 | n/a | 1 | Sep 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $116 | $301.17 | n/a | 1 | Aug 28, 2013 |
Personalis
Jul 17, 2026
Maintained: Buy
Price Target: n/a
Current: $11.98
Upside: -
CareDx
Jul 16, 2026
Maintained: Hold
Price Target: $35
Current: $36.36
Upside: -3.74%
J.B. Hunt Transport Services
Jul 9, 2026
Maintained: Buy
Price Target: n/a
Current: $280.96
Upside: -
NeoGenomics
Jul 9, 2026
Maintained: Buy
Price Target: n/a
Current: $13.14
Upside: -
Natera
Jul 9, 2026
Maintained: Buy
Price Target: n/a
Current: $258.03
Upside: -
Strata Critical Medical
Jun 26, 2026
Maintained: Buy
Price Target: n/a
Current: $5.14
Upside: -
GeneDx Holdings
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $60.54
Upside: -
SOPHiA GENETICS
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $5.65
Upside: -
Sera Prognostics
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $2.05
Upside: +192.68%
Veracyte
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $55.61
Upside: -
May 14, 2026
Maintained: Buy
Price Target: $3
Current: $0.418
Upside: +617.70%
May 6, 2026
Rated: Buy
Price Target: $10
Current: $5.45
Upside: +83.49%
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $16.83
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $22.54
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $22.22
Upside: -
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $3.07
Upside: -
Mar 11, 2026
Rated: Buy
Price Target: $10
Current: $4.40
Upside: +127.27%
Feb 20, 2026
Rated: Buy
Price Target: $125
Current: $145.47
Upside: -14.07%
Oct 29, 2025
Maintained: Buy
Price Target: n/a
Current: $13.31
Upside: -
Oct 23, 2025
Maintained: Buy
Price Target: n/a
Current: $7.75
Upside: -
Aug 18, 2025
Reiterated: Buy
Price Target: $5
Current: $1.35
Upside: +270.37%
Jun 27, 2025
Maintained: Buy
Price Target: n/a
Current: $244.45
Upside: n/a
Jun 25, 2025
Maintained: Buy
Price Target: n/a
Current: $37.46
Upside: n/a
May 5, 2025
Maintained: Buy
Price Target: n/a
Current: $19.09
Upside: n/a
Mar 10, 2025
Maintained: Buy
Price Target: n/a
Current: $19.71
Upside: n/a
Feb 21, 2025
Maintained: Buy
Price Target: n/a
Current: $5.74
Upside: n/a
Feb 19, 2025
Maintained: Buy
Price Target: n/a
Current: $11.41
Upside: n/a
Feb 12, 2025
Maintained: Buy
Price Target: n/a
Current: $131.06
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: n/a
Current: $24.11
Upside: n/a
Feb 6, 2025
Maintained: Buy
Price Target: n/a
Current: $282.52
Upside: n/a
Feb 4, 2025
Maintained: Hold
Price Target: n/a
Current: $77.64
Upside: n/a
Jan 31, 2025
Rated: Buy
Price Target: n/a
Current: $16.44
Upside: n/a
Jan 21, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $16.53
Upside: n/a
Jan 17, 2025
Maintained: Buy
Price Target: $21
Current: $11.94
Upside: n/a
Nov 15, 2024
Reiterated: Buy
Price Target: $4
Current: $1.03
Upside: n/a
Sep 18, 2024
Rated: Buy
Price Target: n/a
Current: $1.06
Upside: n/a
Sep 12, 2024
Rated: Buy
Price Target: $6
Current: $6.06
Upside: n/a
Aug 20, 2024
Rated: Buy
Price Target: n/a
Current: $35.14
Upside: n/a
Jul 9, 2024
Maintained: Buy
Price Target: n/a
Current: $2.06
Upside: n/a
Jun 20, 2024
Rated: Buy
Price Target: n/a
Current: $14.89
Upside: n/a
Feb 13, 2017
Initiated Coverage: Buy
Price Target: $48
Current: $113.88
Upside: n/a
Nov 9, 2016
Downgraded: Hold
Price Target: n/a
Current: $61.51
Upside: n/a
Oct 23, 2015
Downgraded: Hold
Price Target: n/a
Current: $9.15
Upside: n/a
Apr 9, 2015
Initiated Coverage: Buy
Price Target: $7
Current: $21.81
Upside: n/a
Jan 29, 2015
Downgraded: Hold
Price Target: n/a
Current: $21.97
Upside: n/a
Sep 19, 2013
Initiated Coverage: Buy
Price Target: $74
Current: $231.84
Upside: n/a
Aug 28, 2013
Initiated Coverage: Buy
Price Target: $116
Current: $301.17
Upside: n/a